Fatty acid compositions of lipids in mesenteric adipose tissue and lymphoid cells in patients with and without Crohn's disease and their therapeutic implications

Inflammatory Bowel Diseases

Volumn 11, Issue 9, 2005, Pages 820-827

  Westcott, Edward ^a,b,c   Windsor, Alastair ^c   Mattacks, Christine ^b   Pond, Caroline ^b   Knight, Stella ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b OPEN UNIVERSITY   (United Kingdom)

^c ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Arachidonic acid; Lymph nodes; Perinodal adipose tissue; Site specific properties; Triacylglycerols

Indexed keywords

ARACHIDONIC ACID; EDIBLE OIL; FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DEPLETION; DIET THERAPY; ELEMENTAL DIET; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE LYMPHATIC TISSUE; LIPID COMPOSITION; LIPID DEPLETION; LYMPHOID CELL; MALE; MESENTERY; MESENTERY ADIPOSE TISSUE; MESENTERY LYMPH NODE; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

ADIPOSE TISSUE; ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, LIQUID; CHROMATOGRAPHY, THIN LAYER; CROHN DISEASE; FATTY ACIDS; FEMALE; HUMANS; LYMPH NODES; MALE; MESENTERY; MIDDLE AGED;

EID: 25444520225     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mib.0000179213.80778.9a     Document Type: Article

References (61)

1. Pond CM. Paracrine relationships between adipose and lymphoid tissues: implications for the mechanism of HIV-associated adipose redistribution syndrome. Trends Immunol. 2003;24:13-18.
2. Pond CM. Paracrine interactions of mammalian adipose tissue. J Exp Zool. 2003;295A:99-110.
3. Westcott EDA, Mattacks CA, Windsor ACJ, et al. Mesenteric hypertrophy in Crohn's disease. A possible explanation of aetiology. Colored Dis. 2003;5(suppl 1):37.
4. Mattacks CA, Pond CM. The effects of feeding suet-enriched chow on site-specific differences in the composition of triacylglycerol fatty acids in adipose tissue and its interactions in vitro with lymphoid cells. Br J Nutr. 1997;77:621-643.
5. Pond CM, Mattacks CA. The source of fatty acids incorporated into proliferating lymphoid cells in immune-stimulated lymph nodes. Br J Nutr. 2003;89:375-382.
6. Mattacks CA, Sadler D, Pond CM. Site-specific differences in the fatty acid compositions of dendritic cells and associated adipose tissue in popliteal depot, mesentery and omentum, and their modulation by chronic inflammation and dietary lipids. Lymph Res Biol. 2004;2:107-129.
7. Mattacks CA, Sadler D, Pond CM. The control of lipolysis in perinodal and other adipocytes by lymph node and adipose tissue-derived dendritic cells in rats. Adipocytes. 2005;1:43-56.
8. Mattacks CA, Sadler D, Pond CM. The cellular structure and lipid/protein composition of adipose tissue surrounding chronically stimulated lymph nodes in rats. J Anat. 2003;202:551-561.
9. Mattacks CA, Sadler D, Pond CM. The effects of dietary lipids on dendritic cells in perinodal adipose tissue during chronic mild inflammation. Br J Nutr. 2004;91:883-891.
10. Stagg AJ, Hart AL, Knight SC, et al. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut. 2003;52:1522-1529.
11. Riol-Blanco L, Iglesias T, Sánchez-Sánchez N, et al. The neuronal protein Kidins220 localizes in a raft compartment at the leading edge of motile immature dendritic cells. Eur J Immunol. 2004;34:108-118.
12. Laulagnier K, Motta C, Hamdi S, et al. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem J. 2004;380:161-171.
13. Morelli AE, Thomson AW. Dendritic cells under the spell of prostaglandins. Trends Immunol. 2003;24:108-111.
14. Maroof A, English NR, Bedford PA, et al. Developing dendritic cells become 'lacy' cells packed with fat and glycogen. Immunology. 2005;115:473-483.
15. Stagg AJ, Hart AL, Knight SC, et al. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. Best Pract Res Clin Gastroenterol. 2004;18:255-270.
16. Donnet-Hughes A, Schiffrin EJ, Turini ME. The intestinal mucosa as a target for dietary polyunsaturated fatty acids. Lipids. 2001;36:1043-1052.
17. Miura S, Tsuzuki Y, Hokari R, et al. Modulation of intestinal immune system by dietary fat intake: Relevance to Crohn's disease. J Gastroenterol Hepatol. 1998;13:1183-1190.
18. Pond CM, Mattacks CA. Interactions between adipose tissue around lymph nodes and lymphoid cells in vitro. J Lipid Res. 1995;36:2219-2231.
19. Mattacks CA, Pond CM. Interactions of noradrenalin and tumour necrosis factor-α, interleukin-4 and interleukin-6 in the control of lipolysis from adipocytes around lymph nodes. Cytokine. 1999;11:334-346.
20. Mueller A, O'Rourke J, Chu P, et al. Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc Natl Acad Sci USA. 2003;100:12289-12294.
21. Pond CM, Mattacks CA. The activation of adipose tissue associated with lymph nodes during the early stages of an immune response. Cytokine. 2002;17:131-139.
22. Mattacks CA, Sadler D, Pond CM. The effects of dietary lipids on adrenergically stimulated lipolysis in perinodal adipose tissue following prolonged activation of a single lymph node. Br J Nutr. 2002;87:375-382.
23. Bell SJ, Rigby R, English N, et al. Migration and maturation of human colonie dendritic cells. J Immunol. 2001;166:4958-4967.
24. Hyams J. Extra-intestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr. 1994;19:7-21.
25. Geerling BJ, van Houwelingen AC, Badart-Smook A, et al. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol. 1999;94:417.
26. Calder PC, Zurier RB. Polyunsaturated fatty acids and rheumatoid arthritis. Curr Opin Clin Nutr Metab Care. 2001;4:115-121.
27. Calder PC. n-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids. 2003;38:343-352.
28. Trebble TM, Arden NK, Wootton SA, et al. Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn's disease. Clin Nutr. 2004;23:647-655.
29. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. BMJ. 1984;288:1859-1862.
30. Munkholm-Larsen P, Rasmussen D, Ronn B, et al. Elemental diet: a therapeutic approach in chronic inflammatory bowel disease. J Intern Med. 1989;225:325-331.
31. Fernández-Bañares F, Cabré E, Esteve-Comas M. et al. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. J Parenter Enteral Nutr. 1995;19:356-364.
32. Verma S, Brown S, Kirkwood B, et al. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol. 2000;95:735-739.
33. Gassull MA, Ferńndez-Bañares F, Cabré E, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut. 2002;51:164-168.
34. Pond CM. The contribution of wild animal biology to human physiology and medicine. Ecoscience. 2003;10:1-9.
35. Mattacks CA, Sadler D, Pond CM. Site-specific differences in the action of NRTI drags on adipose tissue incubated in vitro with lymphoid cells, and their interaction with dietary lipids. Comp Biochem Physiol. 2003; 135C:11-29.
36. Hinds A, Sanders TAB. The effect of increasing levels of dietary fish oil rich in eicosapentaenoic and docosahexaenoic acid on lymphocyte phospholipid fatty acid composition and cell-mediated immunity in the mouse. Br J Nutr. 1993;69:423-429.
37. Yaqoob P, Knapper JA, Webb DH, et al. Effect of olive oil on immune function in middle-aged men. Am J Clin Nutr. 1998;67:129-135.
38. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365-379.
39. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871-1875.
40. Yokota T, Meka CSR, Kouro T, et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol. 2003;171:5091-5099.
41. Raclot T. Selective mobilization of fatty acids from adipose tissue triacylglycerols. Prog Lipid Res. 2003;42:257-288.
42. Treem WR. Can Crohn's (at first) be only skin deep? J Pediatr Gastroenterol Nutr. 1999;28:135-136.
43. Book DT, Smith TL, McNamar JP, et al. Chronic sinonasal disease in patients with inflammatory bowel disease. Am J Rhinol. 2003;17:87-90.
44. Compston JE. Bone marrow and bone: a functional unit. J Endocrinol. 2002;173:387-394.
45. Yokota T, Meka CSR, Medina KL, et al. Paracine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest. 2002;109:1303-1310.
46. Schoon EJ, Geerling BG, Van Dooren IMA, et al. Abnormal bone turnover in long-standing Crohn's disease in remission. Aliment Pharmacol Ther. 2001;15:783-792.
47. Stockbrügger RW, Schoon EJ, Bollani S, et al. Vertebral fractures: A frequent extra-intestinal manifestation in Crohn's disease. Gastroenterology. 2001;120:3180.
48. Greenstein RJ. Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis. 2003;3:507-514.
49. Beard PM, Daniels MJ, Henderson D, et al. Paratuberculosis infection of nonruminant wildlife in Scotland. J Clin Microbiol. 2001;39:1517-1521.
50. Doreau M, Chilliard Y. Digestion and metabolism of dietary fat in farm animals. Br J Nutr. 1997;78:S15-S35.
51. Cooper SL, Sinclair LA, Wilkinson RG, et al. Manipulation of the n-3 polyunsaturated fatty acid content of muscle and adipose tissue in lambs. J Anim Sci. 2004;82:1461-1470.
52. Kleessen B, Kroesen AJ, Buhr HJ, et al. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002;37:1034-1041.
53. Cavaglieri CR, Nishiyama A, Fernandes LC, et al. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003;73:1683-1690.
54. Hontecillas R, Wannemeulher MJ, Zimmerman DR, et al. Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J Nutr. 2002;132:2019-2027.
55. Bassaganya-Riera J, Reynolds K, Martino-Catt S, et al. Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflmmatory bowel disease. Gastroenterology. 2004;127:777-791.
56. Kwon JH, Farrell RJ. Probiotics and inflammatory bowel disease. Bio Drugs. 2003;17:179-186.
57. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis, a pathologic and clinical entity. JAMA. 1932;99:1323-1329.
58. Sheehan AL, Warren BF, Gear MWL, et al. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg. 1992;79:955-958.
59. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology. 1999;117:73-81.
60. Barbier M, Vidal H, Desreumaux P, et al. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol. 2003;27:983-985.
61. Vassalli P. The pathophysiology of tumour necrosis factor. Annu Rev Immunol. 1992;10:411-452.